News
AZTA
33.53
+0.42%
0.14
Azenta (AZTA) Q3 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue Outlook - Has The Bull Case Changed?
Simply Wall St · 1d ago
Weekly Report: what happened at AZTA last week (0803-0807)?
Weekly Report · 2d ago
Azenta Price Target Raised to $35.00/Share From $28.00 by Evercore ISI Group
Dow Jones · 6d ago
Azenta Is Maintained at Outperform by Evercore ISI Group
Dow Jones · 6d ago
Evercore ISI Group Maintains Outperform on Azenta, Raises Price Target to $35
Benzinga · 6d ago
Azenta price target raised to $35 from $28 at Evercore ISI
TipRanks · 6d ago
Azenta (AZTA) Stock Rallies on Revenue Strength as Cash Burn Lingers
Simply Wall St · 08/06 02:24
Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA)
TipRanks · 08/05 18:50
Azenta Is Maintained at Buy by Needham
Dow Jones · 08/05 18:06
Azenta: Buy Rating Reaffirmed as Strong Q3 Trends Support Outlook; $33 Price Target Maintained
TipRanks · 08/04 23:05
Azenta sees FY26 adjusted EBITDA $59M-$62M
TipRanks · 08/04 20:47
Azenta reports Q3 adjusted cont ops EPS 16c, consensus 10c
TipRanks · 08/04 20:40
Azenta sees Q4 adjusted EBITDA 20M-$23M
TipRanks · 08/04 20:40
Azenta Narrows FY2026 Sales Guidance from $603.000M-$621.000M to $613.000M-$618.000M vs $600.458M Est
Benzinga · 08/04 20:31
Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
PR Newswire · 08/04 20:30
Press Release: Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
Dow Jones · 08/04 20:30
Here are the major earnings after the close Tuesday
Seeking Alpha · 08/04 14:00
The Bull Case For Azenta (AZTA) Could Change Following Its Latest Earnings And Revenue Turnaround - Learn Why
Simply Wall St · 08/04 00:29
Weekly Report: what happened at AZTA last week (0727-0731)?
Weekly Report · 08/03 10:21
More
Webull provides a variety of real-time AZTA stock news. You can receive the latest news about Azenta Inc through multiple platforms. This information may help you make smarter investment decisions.
About AZTA
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.